Methotrexate in rheumatoid arthritis: can current knowledge and experience justify its use as a first-line disease-modifying agent?
作者信息
Tariq S, Tariq S M
机构信息
Department of Rheumatology, Hammersmith Hospital, London, UK.
出版信息
Postgrad Med J. 1993 Oct;69(816):775-80. doi: 10.1136/pgmj.69.816.775.
Abstract
摘要
相似文献
1
Methotrexate in rheumatoid arthritis: can current knowledge and experience justify its use as a first-line disease-modifying agent?
Postgrad Med J. 1993 Oct;69(816):775-80. doi: 10.1136/pgmj.69.816.775.
2
[Serious adverse effects of methotrexate therapy in patients with rheumatic arthritis].
Duodecim. 1998;114(21):2187-90.
3
Severe bone marrow suppression in a patient with rheumatoid arthritis on methotrexate.
J Pak Med Assoc. 1993 Dec;43(12):262-3.
4
Methotrexate in rheumatoid arthritis.
Arthritis Rheum. 1988 Mar;31(3):305-14. doi: 10.1002/art.1780310301.
5
Acute bone marrow suppression following one day oral administration of methotrexate.
R I Med J (1974). 1974 Aug;57(8):332-3.
6
Fatal bone marrow toxicity in a patient treated with methotrexate and glafenine for rheumatoid arthritis.
Clin Exp Rheumatol. 1988 Jan-Mar;6(1):97-9.
7
[Acute bone marrow suppression with low-dosage methotrexate].
Ned Tijdschr Geneeskd. 1987 Dec 19;131(51):2369-72.
8
Variability of methotrexate pharmacokinetics and pharmacodynamics.
Agents Actions Suppl. 1988;24:226-35. doi: 10.1007/978-3-0348-9160-8_21.
9
[Severe adverse effect of methotrexate in rheumatoid arthritis. Don't forget security routines in intercurrent disease!].
Lakartidningen. 1997 May 7;94(19):1811-2.
10
Toxicity of low dose methotrexate in rheumatoid arthritis.
J Rheumatol Suppl. 1985 Dec;12 Suppl 12:35-9.
引用本文的文献
1
Methotrexate pneumonitis in a patient with rheumatoid arthritis.
Postgrad Med J. 1997 Sep;73(863):603-4. doi: 10.1136/pgmj.73.863.603.
2
Sulfasalazine. A review of its pharmacological properties and therapeutic efficacy in the treatment of rheumatoid arthritis.
Drugs. 1995 Jul;50(1):137-56. doi: 10.2165/00003495-199550010-00009.
本文引用的文献
1
Therapeutic abortions with a folic acid antagonist, 4-aminopteroylglutamic acid (4-amino P.G.A) administered by the oral route.
Am J Obstet Gynecol. 1952 Jun;63(6):1298-304. doi: 10.1016/s0002-9378(16)38924-4.
2
Therapeutic suppression of tissue reactivity. II. Effect of aminopterin in rheumatoid arthritis and psoriasis.
Am J Med Sci. 1951 Feb;221(2):176-82.
3
Methotrexate guidelines--revised.
J Am Acad Dermatol. 1982 Feb;6(2):145-55. doi: 10.1016/s0190-9622(82)80064-9.
4
Frequency of malignant neoplasms in 248 long-term methotrexate-treated psoriatics. A preliminary study.
Dermatologica. 1983;167(5):260-1. doi: 10.1159/000249793.
5
Acute lung disease associated with low-dose pulse methotrexate therapy in patients with rheumatoid arthritis.
Arthritis Rheum. 1983 Oct;26(10):1269-74. doi: 10.1002/art.1780261015.
6
Accumulation of DNA strand breaks and methotrexate cytotoxicity.
Proc Natl Acad Sci U S A. 1984 Sep;81(18):5694-8. doi: 10.1073/pnas.81.18.5694.
7
Sister chromatid exchange in patients treated with methotrexate for psoriasis.
J Invest Dermatol. 1984 May;82(5):458-9. doi: 10.1111/1523-1747.ep12260950.
8
A controlled two-centre trial of parenteral methotrexate therapy for refractory rheumatoid arthritis.
J Rheumatol. 1984 Dec;11(6):760-3.
9
No increase in second tumors after cytotoxic chemotherapy for gestational trophoblastic tumors.
N Engl J Med. 1983 Mar 3;308(9):473-6. doi: 10.1056/NEJM198303033080901.
10
Liver damage due to methotrexate in patients with psoriasis.
Br Med J. 1971 Mar 20;1(5750):625-30. doi: 10.1136/bmj.1.5750.625.
Zotero 插件